Personalised treatment of haematological malignancies through systems medicine based on single molecules in single cells

Integrative Biology (United Kingdom)

Volumn 5, Issue 5, 2013, Pages 759-767

  Karimiani, Ehsan Ghayoor ^a   Day, Philip ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; NUCLEIC ACID;

BLOOD; CELL POPULATION; CYTOMETRY; DIAGNOSTIC PROCEDURE; FLOW CYTOMETRY; FUNCTIONAL ASSESSMENT; GENE AMPLIFICATION; GENE EXPRESSION; HEMATOLOGIC MALIGNANCY; HIGH RISK POPULATION; HUMAN; INFORMATION RETRIEVAL; LEUKEMIA CELL; MOLECULAR DIAGNOSTICS; MOLECULAR PATHOLOGY; NUCLEIC ACID ANALYSIS; PERSONALIZED MEDICINE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE STUDY; REVIEW; SINGLE CELL ANALYSIS; HEMATOLOGIC DISEASE; METHODOLOGY; PATHOLOGY; SYSTEMS BIOLOGY;

HEMATOLOGIC NEOPLASMS; HUMANS; INDIVIDUALIZED MEDICINE; PATHOLOGY, MOLECULAR; SYSTEMS BIOLOGY;

EID: 84887711802     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c3ib20258e     Document Type: Review

References (71)

1. D. Antolovic et al., Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies BMC Biotechnol. 2010 10 35
2. M. B. Tang T. K. Chong E. S. Tan Y. J. Sun S. H. Tan A comparative study of polymerase chain reaction detection of clonal T-cell receptor gamma chain gene rearrangements using polyacrylamide gel electrophoresis versus fluorescence capillary electrophoresis Ann. Acad. Med. Singap. 2008 37 27 31
3. P. J. Day Miniaturization applied to analysis of nucleic acids in heterogeneous tissues Expert Rev. Mol. Diagn. 2006 6 23 28
4. N. C. Cady S. Stelick M. V. Kunnavakkam C. A. Batt Real-time PCR detection of Listeria monocytogenes using an integrated microfluidics platform Sens. Actuators, B 2005 107 332 341
5. C. S. Zhang J. L. Xu W. L. Ma W. L. Zheng PCR microfluidic devices for DNA amplification Biotechnol. Adv. 2006 24 243 284
6. M. Simanovsky et al., Phenotypic and gene expression diversity of malignant cells in human blast crisis chronic myeloid leukemia Differentiation 2008 76 908 922
7. M. R. Schweiger et al., Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysis PLoS One 2009 4 e5548
8. E. Matutes A. Attygalle A. Wotherspoon D. Catovsky Diagnostic issues in chronic lymphocytic leukaemia (CLL) Best Pract. Res., Clin. Haematol. 2010 23 3 20
9. S. R. Pine et al., Real-time quantitative PCR: standardized detection of minimal residual disease in pediatric acute lymphoblastic leukemia. Polymerase chain reaction J. Pediatr. Hematol./Oncol. 2003 25 103 108
10. V. H. van der Velden P. G. Hoogeveen R. Pieters J. J. van Dongen Impact of two independent bone marrow samples on minimal residual disease monitoring in childhood acute lymphoblastic leukaemia Br. J. Haematol. 2006 133 382 388
11. T. Zhang et al., Inter-laboratory comparison of chronic myeloid leukemia minimal residual disease monitoring: summary and recommendations J. Mol. Diagn. 2007 9 421 430
12. B. Sanchez-Espiridion et al., A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma Blood 2010 116 e12 e17
13. R. V. Lloyd et al., Analysis of pituitary cells by laser capture microdissection Methods Mol. Biol. 2005 293 233 241
14. C. Compton Getting to personalized cancer medicine: taking out the garbage Cancer 2007 110 1641 1643
15. P. Van Osta Extracting quantitative information from tissue - an industrial perspective Cytometry, Part A 2006 69 588 591
16. M. Verma et al., Mathematical modelling of miRNA mediated BCR.ABL protein regulation in chronic myeloid leukaemia vis-a-vis therapeutic strategies Integr. Biol. 2013 24 543 554
17. W. Kolch C. Neususs M. Pelzing H. Mischak Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery Mass Spectrom. Rev. 2005 24 959 977
18. A. Demurtas et al., Tissue flow cytometry immunophenotyping in the diagnosis and classification of non-Hodgkin's lymphomas: A retrospective evaluation of 1792 cases Cytometry, Part B 2013 84 82 95
19. T. I. George Malignant or benign leukocytosis Hematology Am. Soc. Hematol. Educ. Program 2012 2012 475 484
20. D. Campana E. Coustan-Smith Detection of minimal residual disease in acute leukemia by flow cytometry Cytometry 1999 38 139 152
21. S. Schnittger C. Schoch Quantitative PCR based minimal residual disease detection in core binding factor leukemias: prognostication and guiding of therapy Leuk. Res. 2006 30 657 658
22. L. Grubach et al., Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia Eur. J. Haematol. 2008 81 112 122
23. N. Goasguen et al., Evidence of heterogeneity within colorectal liver metastases for allelic losses, mRNA level expression and in vitro response to chemotherapeutic agents Int. J. Cancer 2010 127 1028 1037
24. J. Mackay O. Landt Real-time PCR fluorescent chemistries Methods Mol. Biol. 2007 353 237 261
25. S. A. Bustin V. Benes T. Nolan M. W. Pfaffl Quantitative real-time RT-PCR - a perspective J. Mol. Endocrinol. 2005 34 597 601
26. I. M. Mackay K. E. Arden A. Nitsche Real-time PCR in virology Nucleic Acids Res. 2002 30 1292 1305
27. A. Stahlberg J. Hakansson X. Xian H. Semb M. Kubista Properties of the reverse transcription reaction in mRNA quantification Clin. Chem. 2004 50 509 515
28. S. A. Bustin et al., The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments Clin. Chem. 2009 55 611 622
29. G. J. Netto R. D. Saad P. A. Dysert, 2nd Diagnostic molecular pathology: current techniques and clinical applications, part I Proc. (Bayl. Univ. Med. Cent.) 2003 16 379 383
30. A. S. Yong J. V. Melo The impact of gene profiling in chronic myeloid leukaemia Best Pract. Res., Clin. Haematol. 2009 22 181 190
31. G. A. Calin R. Garzon A. Cimmino M. Fabbri C. M. Croce MicroRNAs and leukemias: how strong is the connection? Leuk. Res. 2006 30 653 655
32. K. M. Linton et al., Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours Br. J. Cancer 2008 98 1403 1414
33. F. C. Eberle et al., Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens J. Mol. Diagn. 2010 12 394 401
34. J. Budczies et al., Genome-wide gene expression profiling of formalin-fixed paraffin-embedded breast cancer core biopsies using microarrays J. Histochem. Cytochem. 2011 59 146 157
35. A. Aguilar-Mahecha S. Hassan C. Ferrario M. Basik Microarrays as validation strategies in clinical samples: tissue and protein microarrays Omics 2006 10 311 326
36. A. Gazel R. I. Nijhawan R. Walsh M. Blumenberg Transcriptional profiling defines the roles of ERK and p38 kinases in epidermal keratinocytes J. Cell Physiol. 2008 215 292 308
37. W. Shih R. Chetty M. S. Tsao Expression profiling by microarrays in colorectal cancer (Review) Oncol. Rep. 2005 13 517 524
38. S. Lehmann et al., Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia Cancer 2008 112 1296 1305
39. R. M. Shai Microarray tools for deciphering complex diseases Front. Biosci. 2006 11 1414 1424
40. Z. Chen et al., Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer J. Urol. 2003 169 1316 1319
41. N. Altman Replication, variation and normalisation in microarray experiments Appl. Bioinformatics 2005 4 33 44
42. D. Murphy Gene expression studies using microarrays: principles, problems, and prospects Adv. Physiol. Educ. 2002 26 256 270
43. V. S. Warneke et al., Her2/neu testing in gastric cancer: evaluating the risk of sampling errors Ann. Oncol. 2012 24 725 733
44. N. Nakamura et al., Laser capture microdissection for analysis of single cells Methods Mol. Med. 2007 132 11 18
45. E. F. Petricoin K. C. Zoon E. C. Kohn J. C. Barrett L. A. Liotta Clinical proteomics: translating benchside promise into bedside reality Nat. Rev. Drug Discov. 2002 1 683 695
46. D. Greco et al., Physiology, pathology and relatedness of human tissues from gene expression meta-analysis PLoS One 2008 3 e1880
47. Y. W. Kong D. Ferland-McCollough T. J. Jackson M. Bushell microRNAs in cancer management Lancet Oncol. 2012 13 e249 e258
48. J. C. Venter et al., Environmental genome shotgun sequencing of the Sargasso Sea Science 2004 304 66 74
49. E. F. DeLong Microbial community genomics in the ocean Nat. Rev. Microbiol. 2005 3 459 469
50. A. Pini A. Giuliani C. Ricci Y. Runci L. Bracci Strategies for the construction and use of peptide and antibody libraries displayed on phages Curr. Protein Pept. Sci. 2004 5 487 496
51. A. Manome et al., Application of gel microdroplet and flow cytometry techniques to selective enrichment of non-growing bacterial cells FEMS Microbiol. Lett. 2001 197 29 33
52. T. Katsuragi S. Tanaka S. Nagahiro Y. Tani Gel microdroplet technique leaving microorganisms alive for sorting by flow cytometry J. Microbiol. Methods 2000 42 81 86
53. L. Chen A. Manz P. J. Day Whole genome amplification on poly(dimethylsiloxane) microchip array Anal. Biochem. 2008 372 128 130
54. K. Zhang et al., Sequencing genomes from single cells by polymerase cloning Nat. Biotechnol. 2006 24 680 686
55. M. Hashimoto F. Barany S. A. Soper Polymerase chain reaction/ligase detection reaction/hybridization assays using flow-through microfluidic devices for the detection of low-abundant DNA point mutations Biosens. Bioelectron. 2006 21 1915 1923
56. J. Khandurina A. Guttman Bioanalysis in microfluidic devices J. Chromatogr., A 2002 943 159 183
57. M. Okochi H. Tsuchiya F. Kumazawa M. Shikida H. Honda Droplet-based gene expression analysis using a device with magnetic force-based-droplet-handling system J. Biosci. Bioeng. 2010 109 193 197
58. E. Day P. H. Dear F. McCaughan Digital PCR strategies in the development and analysis of molecular biomarkers for personalized medicine Methods 2012 59 101 107
59. H. G. Goh et al., Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay Leuk. Lymphoma 2012 52 896 904
60. M. Bengtsson A. Stahlberg P. Rorsman M. Kubista Gene expression profiling in single cells from the pancreatic islets of Langerhans reveals lognormal distribution of mRNA levels Genome Res. 2005 15 1388 1392
61. F. Kamme et al., Single-cell microarray analysis in hippocampus CA1: demonstration and validation of cellular heterogeneity J. Neurosci. 2003 23 3607 3615
62. T. Nakayama et al., Circumventing air bubbles in microfluidic systems and quantitative continuous-flow PCR applications Anal. Bioanal. Chem. 2006 386 1327 1333
63. A. Gonzalez et al., Gene transcript amplification from cell lysates in continuous-flow microfluidic devices Biomed. Microdevices 2007 9 729 736
64. E. Paietta Assessing minimal residual disease (MRD) in leukemia: a changing definition and concept? Bone Marrow Transplant. 2002 29 459 465
65. V. Srinivasan V. K. Pamula R. B. Fair An integrated digital microfluidic lab-on-a-chip for clinical diagnostics on human physiological fluids Lab Chip 2004 4 310 315
66. R. T. Cunningham et al., Feasibility of a clinical chemical analysis approach to predict misuse of growth promoting hormones in cattle Anal. Chem. 2009 81 977 983
67. M. Okochi H. Tsuchiya F. Kumazawa M. Shikida H. Honda Droplet-based gene expression analysis using a device with magnetic force-based-droplet-handling system J. Biosci. Bioeng. 2009 109 193 197
68. V. Copois et al., Assessment of RNA quality extracted from laser-captured tissues using miniaturized capillary electrophoresis Lab. Invest. 2003 83 599 602
69. M. C. Muller et al., Standardization of preanalytical factors for minimal residual disease analysis in chronic myelogenous leukemia Acta Haematol. 2004 112 30 33
70. K. Dettmer P. A. Aronov B. D. Hammock Mass spectrometry-based metabolomics Mass Spectrom. Rev. 2007 26 51 78
71. D. Majumder A. Mukherjee A passage through systems biology to systems medicine: adoption of middle-out rational approaches towards the understanding of therapeutic outcomes in cancer Analyst 2011 136 663 678